Cite
HARVARD Citation
Jackson, C. et al. (n.d.). 171P Pharmacodynamic (PD) biomarker analysis from CheckMate (CM) 8KX: A multitumor study of a subcutaneous (SC) formulation of nivolumab (NIVO) monotherapy. Immuno-oncology technology. p. . [Online].